Clinical Trials List
Protocol NumberHN-B10-LBPA-003
Active
2025-03-01 - 2027-02-28
Phase I/II
Recruiting2
ICD-10C71.0
Malignant neoplasm of cerebrum, except lobes and ventricles
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9191.0
Malignant neoplasm of cerebrum, except lobes and ventricles
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
10 participants
